These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23196794)

  • 21. PAX2 and PAX8: useful markers for metastatic effusions.
    Waters L; Crumley S; Truong L; Mody D; Coffey D
    Acta Cytol; 2014; 58(1):60-6. PubMed ID: 24334997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PAX8 Expression in a Subset of Malignant Peritoneal Mesotheliomas and Benign Mesothelium has Diagnostic Implications in the Differential Diagnosis of Ovarian Serous Carcinoma.
    Chapel DB; Husain AN; Krausz T; McGregor SM
    Am J Surg Pathol; 2017 Dec; 41(12):1675-1682. PubMed ID: 28877056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Value of mesothelin immunostaining in the diagnosis of mesothelioma.
    Ordóñez NG
    Mod Pathol; 2003 Mar; 16(3):192-7. PubMed ID: 12640097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utility of paired box gene 8 (PAX8) expression in fluid and fine-needle aspiration cytology: an immunohistochemical study of metastatic ovarian serous carcinoma.
    McKnight R; Cohen C; Siddiqui MT
    Cancer Cytopathol; 2010 Oct; 118(5):298-302. PubMed ID: 20572292
    [TBL] [Abstract][Full Text] [Related]  

  • 25. h-Caldesmon, a useful positive marker in the diagnosis of pleural malignant mesothelioma, epithelioid type.
    Comin CE; Dini S; Novelli L; Santi R; Asirelli G; Messerini L
    Am J Surg Pathol; 2006 Apr; 30(4):463-9. PubMed ID: 16625092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HEG1 Is a Highly Specific and Sensitive Marker of Epithelioid Malignant Mesothelioma.
    Naso JR; Tsuji S; Churg A
    Am J Surg Pathol; 2020 Aug; 44(8):1143-1148. PubMed ID: 32205484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The "Brescia panel" (Claudin-4 and BRCA-associated protein 1) in the differential diagnosis of mesotheliomas with epithelioid features versus metastatic carcinomas.
    Bernardi L; Bizzarro T; Pironi F; Szymczuk S; Buda R; Fabbri E; Di Claudio G; Rossi G
    Cancer Cytopathol; 2021 Apr; 129(4):275-282. PubMed ID: 33045147
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of PAX2 in papillary serous carcinoma of the ovary: immunohistochemical evidence of fallopian tube or secondary Müllerian system origin?
    Tong GX; Chiriboga L; Hamele-Bena D; Borczuk AC
    Mod Pathol; 2007 Aug; 20(8):856-63. PubMed ID: 17529925
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical analysis of peritoneal mesothelioma and primary and secondary serous carcinoma of the peritoneum: antibodies to estrogen and progesterone receptors are useful.
    Barnetson RJ; Burnett RA; Downie I; Harper CM; Roberts F
    Am J Clin Pathol; 2006 Jan; 125(1):67-76. PubMed ID: 16482993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. PAX2 and PAX8 reliably distinguishes ovarian serous tumors from mucinous tumors.
    Wang M; Ma H; Pan Y; Xiao W; Li J; Yu J; He J
    Appl Immunohistochem Mol Morphol; 2015 Apr; 23(4):280-7. PubMed ID: 24992169
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PAX8 and PAX2 immunostaining facilitates the diagnosis of primary epithelial neoplasms of the male genital tract.
    Tong GX; Memeo L; Colarossi C; Hamele-Bena D; Magi-Galluzzi C; Zhou M; Lagana SM; Harik L; Oliver-Krasinski JM; Mansukhani M; Falcone L; Hibshoosh H; O'Toole K
    Am J Surg Pathol; 2011 Oct; 35(10):1473-83. PubMed ID: 21934480
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The differential diagnosis of primary peritoneal papillary tumors.
    Gitsch G; Tabery U; Feigl W; Breitenecker G
    Arch Gynecol Obstet; 1992; 251(3):139-44. PubMed ID: 1376598
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The diagnostic utility of immunohistochemistry in distinguishing between mesothelioma and renal cell carcinoma: a comparative study.
    Ordóñez NG
    Hum Pathol; 2004 Jun; 35(6):697-710. PubMed ID: 15188136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uroplakin-IIIb as a novel immunohistochemical marker for mesothelioma.
    van Pel DM; Cheung S; Ionescu DN; Churg A
    Hum Pathol; 2023 Nov; 141():64-68. PubMed ID: 37776956
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flat pattern of nephrogenic adenoma: previously unrecognized pattern unveiled using PAX2 and PAX8 immunohistochemistry.
    Piña-Oviedo S; Shen SS; Truong LD; Ayala AG; Ro JY
    Mod Pathol; 2013 Jun; 26(6):792-8. PubMed ID: 23328975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas.
    Nonaka D; Chiriboga L; Soslow RA
    Am J Surg Pathol; 2008 Oct; 32(10):1566-71. PubMed ID: 18724243
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic utility of PAX8 and PAX2 immunohistochemistry in the identification of metastatic Müllerian carcinoma in effusions.
    Wiseman W; Michael CW; Roh MH
    Diagn Cytopathol; 2011 Sep; 39(9):651-6. PubMed ID: 20949455
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PAX8 and PAX2 expression in endocervical adenocarcinoma in situ and high-grade squamous dysplasia.
    Shukla A; Thomas D; Roh MH
    Int J Gynecol Pathol; 2013 Jan; 32(1):116-21. PubMed ID: 23202787
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunohistochemical expression of PAX8, PAX2, and cytokeratin in melanomas.
    Plotzke JM; Zhao R; Hrycaj SM; Harms PW; Mehra R; Chan MP
    J Cutan Pathol; 2021 Oct; 48(10):1246-1251. PubMed ID: 33934372
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Rab25 is overexpressed in Müllerian serous carcinoma compared to malignant mesothelioma.
    Brusegard K; Stavnes HT; Nymoen DA; Flatmark K; Trope CG; Davidson B
    Virchows Arch; 2012 Feb; 460(2):193-202. PubMed ID: 22249560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.